PAS: Motavizumab Cuts RSV Infection and Hospitalization Rates

Courtesy MedPage Today Infectious Disease  Mon, 05/05/2008 - 11:24

HONOLULU -- Motavizumab, a humanized monoclonal antibody to respiratory syncytial virus (RSV) reduced hospital admissions among American-Indian infants by 83% compared with placebo, in a phase III study, researchers reported here.


 

More related items

British Medical Journal: Brain drain starts at age...
The mental decline associated with aging starts as early as 45 — about 15 years sooner than previously thought, according to a ground-breaking new study. Researchers tested the memory,...

Heart disease study highlights Scottish ethnic groups...
(University of Edinburgh) Scots of Pakistani origin are 50 percent more likely to be admitted to hospital with chest pain and angina than those of Indian ethnicity, a study has found.Scots of...

New method boosts blood-clotting for hemophiliacs
ATLANTA (AP) -- In what's being called a landmark study, researchers used gene therapy to successfully treat six patients with severe hemophilia, a blood-clotting disorder....

Burt's Bees - Baby Bee Buttermilk Lotion, 7 fl oz...
Baby Bee Buttermilk Lotion contains only Mother Nature's safe and gentle ingredients, and is enriched with vitamin E, Aloe Vera and Buttermilk to provide soothing and nourishing emollients...

ghd MK4 Professional Advanced Ceramic Heat-Styler, 1"
Endorsed by the world's top session stylists and hottest celebrities, the revolutionary, professional ghd MK4 original ceramic styling iron is everybody's number one must-have beauty...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com